LXEO Lexeo Therapeutics PE ratio, current and historical analysis
The current PE ratio of LXEO can't be determined, as the TTM EPS of -$3.09 is negative. The last PE ratio of Lexeo Therapeutics, recorded in September 2024, was 0.52.
LXEO PE ratio history
How has LXEO's PE ratio performed in the past
Today
N/A
Average
N/A
Median
N/A
Minimum
N/A
Maximum
N/A
Lexeo Therapeutics PE ratio by year
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | N/A | N/A | $6.58 | -$3.09 |
| 2023 | N/A | N/A | $13.42 | -$12.4 |
| 2022 | N/A | N/A | N/A | -$36.36 |
| 2021 | N/A | N/A | N/A | -$32.6 |
Lexeo Therapeutics PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Dec 2024 | N/A | N/A | $6.58 | -$3.09 |
| Sep 2024 | 0.52 | -80.3% | $9.04 | $17.54 |
| Jun 2024 | 2.64 | N/A | $16.04 | $6.07 |
| Mar 2024 | N/A | N/A | $15.68 | -$1.59 |
| Dec 2023 | N/A | N/A | $13.42 | -$12.4 |
| Sep 2023 | N/A | N/A | N/A | -$41.1 |
| Jun 2023 | N/A | N/A | N/A | -$39.12 |
| Mar 2023 | N/A | N/A | N/A | -$40.05 |
| Dec 2022 | N/A | N/A | N/A | -$36.36 |
| Sep 2022 | N/A | N/A | N/A | N/A |
| Jun 2022 | N/A | N/A | N/A | N/A |
| Dec 2021 | N/A | N/A | N/A | -$32.6 |
LXEO average PE ratio chart
What is the average PE ratio of LXEO for the past years
3-year avg
N/A
5-year avg
N/A
10-year avg
N/A
15-year avg
N/A
LXEO PE vs peers
What is LXEO's PE ratio compared to its peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| NTLA Intellia Therapeutics Inc | N/A | $725.66M |
| BLUE bluebird bio Inc | N/A | $48.27M |
| CRSP CRISPR Therapeutics AG | N/A | $2.85B |
| EDIT Editas Medicine Inc | N/A | $93.35M |
| QURE uniQure NV | N/A | $524.28M |
| RGNX REGENXBIO Inc | N/A | $329.07M |
| SGMO Sangamo Therapeutics Inc | N/A | $137.97M |
| ADVM Adverum Biotechnologies Inc | N/A | $83M |
| BEAM Beam Therapeutics Inc | N/A | $1.41B |
| VERV Verve Therapeutics Inc | N/A | $339.64M |
| LXEO Lexeo Therapeutics Inc. | N/A | $88.64M |
Frequently asked questions
What is Lexeo Therapeutics's PE ratio?
The current price to earnings ratio of LXEO can't be calculated, as its EPS of -$3.09 is negative.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.